Hwi‐yeol Yun - Concepedia

Author

Hwi‐yeol Yun

Also Known As

H YUN, H. Y. Yun, H.-Y. Yun, H.‐Y. Yun, Heung Tae Kim, Hwi-Yeol Yun, Hwi-yeol YUN, Hwi-yeol Yun, Hwi‐Yeol Yun, Hwi‐yeol Yun

160

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Chungnam National University Seoul National University Daegu Catholic University JW Pharmaceutical (South Korea)Yonsei University

About

Hwi‐yeol Yun is an author at Chungnam National University specializing in medicine, pharmacology, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	568
2	Biochemistry	4	4	56
3	Health Sciences	3	3	68
4	Engineering	1	1	67
5	Blood Transplantation	1	1	21

Hwi‐yeol Yun

Publications

958

Citations

H-Index

Page 1

	Year	Citations
Quantitative analysis of lab-to-lab variability in Caco-2 permeability assays Jong Bong Lee, Atheer Zgair, Dhiaa A. Taha, European Journal of Pharmaceutics and Biopharmaceutics BioanalysisMass SpectrometryQuantitative AnalysisAnalytical ChemistryElectrophysiology	2017	91
Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients Nayoung Han, Hwi‐yeol Yun, Jin-yi Hong, European Journal of Clinical Pharmacology TransplantationKidney TransplantMedicineKidney TransplantationPharmacology	2012	73
Fine-tuning of BERT Model to Accurately Predict Drug–Target Interactions Hyeunseok Kang, Sungwoo Goo, Hyunjung Lee, Pharmaceutics Drug TargetEngineeringMachine LearningPharmacodynamic ModelingBiomedical Text Mining	2022	67
External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipients Junjun Mao, Zheng Jiao, Hwi‐yeol Yun, British Journal of Clinical Pharmacology	2017	64
Population Pharmacokinetic–Pharmacogenetic Model of Tacrolimus in the Early Period after Kidney Transplantation Nayoung Han, Soojung Ha, Hwi‐yeol Yun, Basic & Clinical Pharmacology & Toxicology	2013	52
ABCB1 C3435T Genetic Polymorphism on Population Pharmacokinetics of Methotrexate After Hematopoietic Stem Cell Transplantation in Korean Patients: A Prospective Analysis In‐Wha Kim, Hwi‐yeol Yun, Boyoon Choi, Clinical Therapeutics Hematological MalignancyTransplantationStem Cell TransplantationHematologyGenetic Epidemiology	2012	37
Effects of type 2 diabetes mellitus on the population pharmacokinetics of rifampin in tuberculosis patients Min Jung Chang, Jung‐woo Chae, Hwi‐yeol Yun, Tuberculosis Metabolic SyndromeDiabetes ManagementDiabetesPharmacologyType 2	2014	35
Increased Exposure of Tacrolimus by Co-administered Mycophenolate Mofetil: Population Pharmacokinetic Analysis in Healthy Volunteers Jae Hyun Kim, Nayoung Han, Myeong Gyu Kim, Scientific Reports	2018	35
Population pharmacokinetics of moxifloxacin, cycloserine, p -aminosalicylic acid and kanamycin for the treatment of multi-drug-resistant tuberculosis Min Jung Chang, Byung Hak Jin, Jung‐woo Chae, International Journal of Antimicrobial Agents	2017	32
The Effects of Food on the Bioavailability of Fenofibrate Administered Orally in Healthy Volunteers via Sustained-Release Capsule Hwi‐yeol Yun, Eun Joo Lee, Soo Youn Chung, Clinical Pharmacokinetics NutritionPharmacological StudyHealthy VolunteersPharmacologyFenofibrate Administered Orally	2006	29

Page 1